GTYH yields 31.75% · JNJ yields 2.13%● Live data
📍 GTYH pulled ahead of the other in Year 1
Combined, GTYH + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GTYH + JNJ for your $10,000?
GTY Technology Holdings Inc. operates as a software-as-a-service (SaaS) company that offers a cloud-based suite of solutions for the public sector in North America. The company develops software technologies for the procurement and vendor or supplier sourcing industry in government, public sector, and various highly-regulated commercial vertical markets; and content, digital, and integrated payment services via a SaaS platform for government agencies and utility companies. It also provides cloud-based grants management and cost allocation software for state, local, and tribal governments; software to streamline municipal permissions and licenses; budgeting software, performance management, and transparency and data visualization solutions; and public sector budgeting SaaS, software, and consulting services. GTY Technology Holdings Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts. As of July 7, 2022, GTY Technology Holdings Inc. was taken private.
Full GTYH Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.